These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 21248628)
1. Risk of perioperative transfusion in elective hepatectomy. Cockbain AJ; Goldsmith PJ; Prasad KR Ann Surg; 2011 Mar; 253(3):631; author reply 632. PubMed ID: 21248628 [No Abstract] [Full Text] [Related]
2. Perioperative transfusion risk assessment with elective hepatectomy. Ramacciato G; Sagnotta A; Nigri G Ann Surg; 2011 Mar; 253(3):629-30; author reply 630-1. PubMed ID: 21248629 [No Abstract] [Full Text] [Related]
3. Surgery for hepatic cancer: are we making progress? Scoggins CR J Ky Med Assoc; 2006 Jan; 104(1):19-25. PubMed ID: 16438401 [No Abstract] [Full Text] [Related]
8. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma. Kim KH; Lee SG; Park EH; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ Ann Surg Oncol; 2009 Mar; 16(3):623-9. PubMed ID: 19130133 [TBL] [Abstract][Full Text] [Related]
9. Right trisectionectomy of the liver for intrahepatic cholangiocarcinoma with bile duct invasion in a Jehovah's Witness. Nishida S; Madariaga JR; Santiago S; Quintini C; Palaios E; Gyamfi A; Rico R; Hamamura K; Haider H; Moon JI; Levi DM; Casillas VJ; Bejarano PA; Tzakis AG J Hepatobiliary Pancreat Surg; 2007; 14(3):312-7. PubMed ID: 17520209 [TBL] [Abstract][Full Text] [Related]
10. [Evaluation of risk factors in the development of postoperative complications in patients undergoing liver resection for cancer]. Staudacher C; Chiappa A; Zbar AP; Bertani E; Biella F; Haizhen Z Chir Ital; 2000; 52(2):123-9. PubMed ID: 10832537 [TBL] [Abstract][Full Text] [Related]
14. Intrahepatic cholangiocarcinoma detected by elevated levels of alpha-fetoprotein-L3 after hepatectomy for hepatocellular carcinoma in a patient with Budd-Chiari syndrome. Yamamoto M; Otsubo T; Ariizumi S; Nakano M; Takasaki K Int Surg; 2005; 90(2):81-4. PubMed ID: 16119710 [TBL] [Abstract][Full Text] [Related]
15. [Preoperative embolization of the portal vein in liver tumors]. Tarazov PG Vestn Khir Im I I Grek; 2001; 160(1):117-21. PubMed ID: 11258315 [No Abstract] [Full Text] [Related]
16. Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma. Wei AC; Tung-Ping Poon R; Fan ST; Wong J Br J Surg; 2003 Jan; 90(1):33-41. PubMed ID: 12520572 [TBL] [Abstract][Full Text] [Related]
17. Clinical presentation and management of intrahepatic cholangiocarcinoma. Farges O; Fuks D Gastroenterol Clin Biol; 2010 Mar; 34(3):191-9. PubMed ID: 20202770 [No Abstract] [Full Text] [Related]
18. Factors for prolonged length of stay after elective hepatectomy for hepatocellular carcinoma. The surgeon's role in the managed care era. Hsia CY; Chau GY; King KL; Loong CC; Lui WY; Wu CW Hepatogastroenterology; 2003; 50(51):798-804. PubMed ID: 12828088 [TBL] [Abstract][Full Text] [Related]
19. Combined hepatocellular and cholangiocellular carcinoma. Murakami T; Kim T; Tomoda K; Narumi Y; Sakon M; Wakasa K; Nakamura H Radiat Med; 1997; 15(4):243-6. PubMed ID: 9311042 [TBL] [Abstract][Full Text] [Related]
20. Autologous blood transfusion for hepatectomy in patients with cirrhosis and hepatocellular carcinoma: use of recombinant human erythropoietin. Kajikawa M; Nonami T; Kurokawa T; Hashimoto S; Harada A; Nakao A; Takagi H Surgery; 1994 Jun; 115(6):727-34. PubMed ID: 8197566 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]